Price
$6.03
Increased by +3.97%
Dollar volume (20D)
13.46 M
ADR%
4.75
Earnings report date
Nov 10, 2025
Shares float
72.70 M
Shares short
10.28 M [14.14%]
Shares outstanding
102.43 M
Market cap
594.11 M
Beta
-1.27
Price/earnings
N/A
20D range
5.63 7.40
50D range
5.63 7.40
200D range
5.63 16.76

Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.

The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage.

It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers.

Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Aug 5, 25 -0.29
Decreased by -480.00%
-0.35
Increased by +17.38%
May 6, 25 -0.35
Increased by +51.39%
-0.42
Increased by +16.67%
Feb 25, 25 -0.63
Increased by +1.56%
-0.46
Decreased by -36.22%
Oct 30, 24 0.38
Increased by +170.37%
-0.32
Increased by +220.41%
Jul 30, 24 -0.05
Increased by +91.80%
-0.75
Increased by +93.33%
May 6, 24 -0.72
Decreased by -22.03%
-0.66
Decreased by -9.09%
Feb 26, 24 -0.64
Decreased by -14.29%
-0.58
Decreased by -10.34%
Nov 6, 23 -0.54
Decreased by -1.89%
-0.60
Increased by +10.00%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 25 30.76 M
Increased by +N/A%
-36.00 M
Increased by +42.33%
Decreased by -117.02%
Decreased by N/A%
Dec 31, 24 29.21 M
Increased by +5.12 K%
-65.71 M
Decreased by -20.55%
Decreased by -224.99%
Increased by +97.69%
Sep 30, 24 93.76 M
Increased by +N/A%
37.04 M
Increased by +180.25%
Increased by +39.50%
Decreased by N/A%
Jun 30, 24 8.19 M
Increased by +N/A%
-4.41 M
Increased by +90.39%
Decreased by -53.80%
Decreased by N/A%
Mar 31, 24 0.00
Decreased by N/A%
-62.41 M
Decreased by -76.42%
Decreased by N/A%
Decreased by N/A%
Dec 31, 23 560.00 K
Increased by +N/A%
-54.51 M
Decreased by -56.57%
Decreased by -9.73 K%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-46.15 M
Decreased by -35.75%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-45.86 M
Decreased by -25.55%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY